Literature DB >> 10702527

Total protein determination in urine: elimination of a differential response between the coomassie blue and pyrogallol red protein dye-binding assays.

T Marshall1, K M Williams.   

Abstract

BACKGROUND: The total protein content of urine is a good index of renal function, but its determination is unreliable. Protein dye-binding assays are simple, but they characteristically lack a uniform response to different proteins.
METHODS: We investigated a differential response of the Sigma Microprotein Coomassie Brilliant Blue (CBB) and Pyrogallol Red-molybdate (PRM) protein dye-binding assays to urine, using human albumin, albumin/globulin, or urinary protein as calibrator.
RESULTS: The urine protein values (n = 60) obtained with the CBB assay were 110-13 500 mg/L (mean, 2390 mg/L) compared with 160-18 300 mg/L (mean, 3470 mg/L) obtained with the PRM assay (CBB:PRM protein concentration ratio, 0.46-0.88, mean, 0. 69 +/- 0.10). The differential response was highly reproducible as indicated by Sigma urine control Level 1 (within-day CBB:PRM ratio, 0.68 +/- 0.02; between-day CBB:PRM ratio, 0.67 +/- 0.04) and Sigma urine control Level 2 (within-day CBB:PRM ratio, 0.60 +/- 0.01; between-day CBB:PRM ratio, 0.59 +/- 0.02). The use of urinary protein as a calibrator (rather than human albumin) greatly improved the agreement between the assays when applied to urine (y(CBB) = 0. 972x(PRM) - 16 vs y(CBB) = 0.685x(PRM) + 17). In studies using urine controls, this calibrator also improved agreement between the CBB, PRM, trichloroacetic acid (TCA), and benzethonium chloride protein methods and, to a lesser extent, agreement with the TCA-Ponceau S method.
CONCLUSION: The use of a urinary protein calibrator improves the agreement between different methods used to determine total protein in urine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702527

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Application of an improved biuret method to the determination of total protein in urine and cerebrospinal fluid without concentration step by use of Hitachi 7170 auto-analyzer.

Authors:  X Guobing; J Lili; Z Lihua; X Tiean
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Simple and reliable method to precipitate proteins from bacterial culture supernatant.

Authors:  Randolph B Caldwell; Claus T Lattemann
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

3.  The application of micro-coil NMR probe technology to metabolomics of urine and serum.

Authors:  John H Grimes; Thomas M O'Connell
Journal:  J Biomol NMR       Date:  2011-03-06       Impact factor: 2.835

4.  Chapter 1: Definition and classification of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

Review 5.  Current state of the art for enhancing urine biomarker discovery.

Authors:  Michael Harpole; Justin Davis; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2016-06       Impact factor: 3.940

6.  Magnetic detection of albuminuria using hematite nanorods synthesized via chemical hydrothermal method.

Authors:  Ali Ramzannezhad; Amir Hayati; Ali Bahari; Hamed Najafi-Ashtiani
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

7.  Studies of benzothiazole and benzoselenazole squaraines as fluorescent probes for albumins detection.

Authors:  Kateryna D Volkova; Vladyslava B Kovalska; Mykhaylo Yu Losytskyy; Artur Bento; Lucinda V Reis; Paulo F Santos; Paulo Almeida; Sergiy M Yarmoluk
Journal:  J Fluoresc       Date:  2008-01-17       Impact factor: 2.217

8.  Improvement of the newly developed latex agglutination test (Katex) for diagnosis of visceral lieshmaniasis.

Authors:  Gholam Reza Hatam; Mohammad Amin Ghatee; Seyed Mohammad Hossein Hossini; Bahador Sarkari
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

9.  Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis.

Authors:  Keiichi Sumida; Girish N Nadkarni; Morgan E Grams; Yingying Sang; Shoshana H Ballew; Josef Coresh; Kunihiro Matsushita; Aditya Surapaneni; Nigel Brunskill; Steve J Chadban; Alex R Chang; Massimo Cirillo; Kenn B Daratha; Ron T Gansevoort; Amit X Garg; Licia Iacoviello; Takamasa Kayama; Tsuneo Konta; Csaba P Kovesdy; James Lash; Brian J Lee; Rupert W Major; Marie Metzger; Katsuyuki Miura; David M J Naimark; Robert G Nelson; Simon Sawhney; Nikita Stempniewicz; Mila Tang; Raymond R Townsend; Jamie P Traynor; José M Valdivielso; Jack Wetzels; Kevan R Polkinghorne; Hiddo J L Heerspink
Journal:  Ann Intern Med       Date:  2020-07-14       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.